The global Baby Nasal Aspirators and Inhalers market is expected to grow significantly by 2027 expanding at a considerable CAGR during the forecast period (2021-2027).

Pneumonia kills more children than any other infectious disease, claiming the lives of over 800,000 children under five every year, or around 2,200 every day. This includes over 153,000 newborns. Surging cased of pneumonia is leading to rising respiratory problems to the babies, therefore, demanding nasal aspirators and inhalers. Globally, there are over 1,400 cases of pneumonia per 100,000 children, or 1 case per 71 children every year, with the greatest incidence occurring in South Asia (2,500 cases per 100,000 children) and West and Central Africa (1,620 cases per 100,000 children). Progress in reducing deaths due to pneumonia in children under five has been significantly slower than for other infectious diseases. Since 2000, under-five deaths due to pneumonia have declined by 54%, while deaths due to diarrhea have decreased by 64% and are now almost half of the pneumonia deaths.

For a detailed analysis of Baby Nasal Aspirators and Inhalers browse through https://univdatos.com/report/baby-nasal-aspirators-and-inhalers-market/

The surging prevalence of chronic respiratory conditions such as asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD) across the globe coupled with the growing risks of respiratory diseases among the children and rising air pollution levels due to rapidly changing climate is generating the demand for the nasal aspirator and inhalers. Asthma is the most common chronic disease among children and inhaled medication can control asthma symptoms and allow people with asthma to lead a normal, active life. As per the Asthma and Allergy Foundation of America, In 2019, 44.3% of children aged 18 and younger who had asthma reported having one or more asthma attacks in the past year. Moreover, about 47.2% of children under the age of 5 with asthma had an episode.
For a detailed analysis of the type in Baby Nasal Aspirators and Inhalers browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=18451

During the COVID-19 pandemic, there were additional risks to children’s health and wellbeing as the pandemic has caused disruptions throughout the health system as well as to the lives of families. As per the American Academy of Pediatrics, reported COVID-19 cases among children spiked dramatically in 2022 during the Omicron variant surge, almost 4.8 million child cases were reported since the beginning of January. For the week ending February 24th, nearly 127,000 additional child COVID-19 cases were reported, down substantially from the peak level of 1,150,000 reported the week ending January 20th and the lowest weekly count since mid-November. A surge in COVID -19 cases; lead to the robust boom in the demand for the aspirators and inhalers for the babies. However, due to the shortage of the products the prices increased very sharply.

Based on the type, the market is fragmented into electric and manual. The manual segment grabbed XX% market share in 2020 and the segment captured USD XX MN market. However, the electric segment would witness the highest CAGR during the forthcoming years. Electric nasal aspirator and inhaler is a convenient solution regardless of the child’s age – newborns, infants, and even older children can benefit from this type of nasal aspirator. It’s powerful and easy to use, that’s why it has become a favorite of many parents.

Based on the application, the market is fragmented into newborns and infants. The infants’ segment captured XX% Market share in 2020. The market of this segment would reach USD XX Mn BY 2027. Respiratory illnesses are common in infancy, including colds, flu, croup, and bronchiolitis. More serious respiratory conditions that can affect infants include asthma and pneumonia. As per the National Institutes of Health, About 1% of newborn infants develop respiratory distress syndrome.

For a detailed analysis of the Region in Baby Nasal Aspirators and Inhalers browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=18451

Additionally, the report provides detailed initiatives that are being taken in the field of Baby Nasal Aspirators and Inhalers. The market is classified into distinct regions including North America (the U.S, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, and United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, and the Rest of APAC), Rest of World has been conducted. North America region grabbed XX% market and captured USD XX Mn market share in 2020. As per American Lung Association, the respiratory syncytial virus is a seasonal illness that has been commonly overlooked even though it affects about 97% of children by the age of two. Severe RSV can be unpredictable. In fact, every year an estimated 58,000 children five and under are hospitalized and RSV is the leading cause of hospitalization in all infants.

Global Baby Nasal Aspirators and Inhalers Market Segmentation

Market Insight, by Type

• Electric
• Manual

Market Insight, by Application

• Newborns
• Infants

Market Insight, by Region

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • France
  • Germany
  • Spain
  • Italy
  • United Kingdom
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
• Rest of World

Top Company Profiles

• NoseFrida
• NUK
• Pigeon
• AViTA
• NeilMed
• Graco
• Béaba
• B.Well Swiss AG
• Magnifeko
• Rumble Tuff